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ABSTRACT
In addition to the diaphragm’s role as the primary respiratory muscle, it also plays an under-recognized role in cardiac
function. It serves as a pump facilitating venous and lymph return, modulating left ventricular afterload hemodynamics
and pericardial pressures, as well as regulating autonomic tone. Heart failure (HF) is associated with diaphragmatic
changes (ie, muscle ﬁber atrophy and weakness, increased ratio of type I to type II muscle ﬁbers, and altered muscle
metaboreﬂex) that lead to diaphragmatic dysfunction with subsequent symptomatic manifestations of HF. Herein, it is
proposed that targeting the diaphragm in patients with HF via inspiratory muscle training or device-based stimulation can
provide a novel treatment pathway for HF. Reviewed are several potential mechanisms through which therapies targeting
the diaphragm can be beneﬁcial in HF (ie, improving preload reserve, atrial and ventricular synchrony, and metaboreﬂex
activity; reducing pericardial restraint; and restoring diaphragm strength). (J Am Coll Cardiol 2022;80:1647–1659)
© 2022 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).

T

he diaphragm is among the largest muscles in

intrathoracic pressure that draws air into the lungs

humans. It is a dome-shaped ﬁbromuscular

during inspiration.1 Relaxation of the diaphragm al-

structure separating the thoracic and abdom-

lows for elastic recoil of the chest wall, reducing

inal cavities. The diaphragm functions as the primary

thoracic cavity size, increasing intrathoracic pressure,

respiratory muscle. Motor neural activation results in

and causing exhalation. 1 The diaphragm also plays an

diaphragmatic contraction, forcing abdominal con-

important role in coughing, speech, swallowing, and

tents caudally and increasing the transverse and lon-

abdominal straining; acts as the “external sphincter”

gitudinal dimensions of the chest cavity. This reduces

of the lower esophagus; and aids in blood return to

From the aDepartment of Medicine, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA; bPerelman School of
Medicine at The University of Pennsylvania, Philadelphia, Pennsylvania, USA; cDivision of Cardiology, Duke University Medical
Center, Durham, North Carolina, USA; dDuke Clinical Research Institute, Duke University School of Medicine, Durham, North
Carolina, USA; eDepartment of Cardiology and Vascular Medicine, West German Heart and Vascular Center, University Hospital
Listen to this manuscript’s

Essen, Hufelandstraße, Essen, Germany; fDivision of Cardiology, Department of Medicine, Medical University of South Carolina,

audio summary by

Charleston, South Carolina, USA; gParkview Mirro Center for Research and Innovation, Parkview Health, Fort Wayne, Indiana,

Editor-in-Chief

USA;

Dr Valentin Fuster on

Computing, Indianapolis, Indiana, USA; iDepartment of Medicine, Indiana University School of Medicine, Indianapolis, Indiana,

www.jacc.org/journal/jacc.

h

Department of BioHealth Informatics, Indiana University–Purdue University Indianapolis School of Informatics and

USA; jRobertson Centre for Biostatistics, Institute of Health and Wellbeing, University of Glasgow, Glasgow, United Kingdom; and
the kNational Heart and Lung Institute, Imperial College, London, United Kingdom.
The authors attest they are in compliance with human studies committees and animal welfare regulations of the authors’
institutions and Food and Drug Administration guidelines, including patient consent where appropriate. For more information,
visit the Author Center.
Manuscript received June 30, 2022; revised manuscript received August 4, 2022, accepted August 5, 2022.

ISSN 0735-1097

https://doi.org/10.1016/j.jacc.2022.08.760

1648

Salah et al

JACC VOL. 80, NO. 17, 2022
OCTOBER 25, 2022:1647–1659

Diaphragm Function and Hemodynamics

ABBREVIATIONS

the heart and lymph return to the thoracic

AND ACRONYMS

duct from the abdominal lymph vessels during inhalation.

ASDS = asymptomatic

1

The diaphragm plays an

synchronized diaphragmatic

under-recognized role in cardiac function

stimulation

and its hemodynamics. In this review, we

AT = aerobic training

discuss the role of the diaphragm on hemo-

CSA = central sleep apnea

dynamics and the diaphragm as a potential
novel therapeutic target in heart failure (HF).

HF = heart failure

ROLE OF THE DIAPHRAGM IN
CARDIOVASCULAR FUNCTION

HFrEF = heart failure with
reduced ejection fraction

HRV = heart rate variability
IMT = inspiratory muscle

The diaphragm plays a major role in modu-

training

lating hemodynamics via acting as a respira-

LV = left ventricle

tory pump that increases systemic venous

LVEF = left ventricular ejection

and lymph return, regulating left ventricular

fraction

(LV) afterload, modulating pericardial pres-

NYHA = New York Heart

sure, regulating heart rate variability (HRV),

Association

and

PIDS = pacing-induced

modulating

arterial

baroreﬂex

sensitivity.

diaphragmatic stimulation

Pimax = maximal inspiratory

ACTING

pressure

LYMPH

A

RESPIRATORY

SYSTEMATIC

RETURN. Diaphragmatic

motion

end-expiration

comorbidities

ﬁlling and stroke volume (ventricular interdependence).5 The fall in LV stroke volume may be
partially offset by an increase in transmural wall

pressures drop, leading to an increase in LV stroke

is

estimated

to

be

and

disease

state

(eg,

tory cycle.2
Respiration acts as a pump for both systemic and
venous

ment into the LV, leading to reduced LV diastolic

displacement favors LV ﬁlling, and aortic diastolic

emphysema, obesity), and time within the respira-

pulmonary

ﬁlling during inspiration causing septal displace-

drives

substantially from lung apex to base, with posture,
sex,

and LV afterload, or increased right ventricular

blood ﬂow to the left atrium increases, septal

about 4 mm Hg. 2 However, pleural pressure varies
age,

 Device-based stimulation of the diaphragm can improve preload reserve,
enhance atrioventricular synchrony, and
reduce pericardial restraint, with potential therapeutic implications for HF.

AND

VENOUS

and expiration. In healthy individuals, pleural presat

 HF is associated with diaphragmatic
dysfunction.

PUMP:

changes in intrathoracic pressure during inspiration
sure

 The diaphragm plays a key role in modulating cardiovascular hemodynamics.

pressure and hence preload. During expiration,

AS

INCREASING

HIGHLIGHTS

systems.

Inspiration reduces

intrathoracic pressure and increases intra-abdominal
pressure creating a pressure gradient that enhances
venous return to the right atrium. The fall in intra-

volume (Figure 1).5
REGULATING LV AFTERLOAD. Contraction of the

diaphragm results in a reduction in intrathoracic
pressure, which imposes an afterload burden on the
LV, resulting in a reduction in LV systolic performance.6 It also results in a decrease in pleural pressure, which is inversely associated with the gradient
between intrathoracic and extrathoracic vasculatures.7 The afterload is highly dependent on this
gradient; therefore, contraction of the diaphragm
(and subsequently reduction in pleural pressure)
would increase the afterload.7

thoracic pressure also increases the pressure gradient

MODULATING PERICARDIAL PRESSURE. Pericardial

across the right atrial and right ventricular walls,

pressure is closely related to heart volumes. At

increasing

normal

myocardial

stretch

(preload),

and

increasing right-sided stroke volume.3

physiological

heart

volumes,

pericardial

pressure is fairly stable. However, an increase in the

Inspiration has similar effects on lymphatic re-

heart volumes beyond the normal range results in

turn. 4 The right lymphatic duct drains lymph from

a marked increase in pericardial pressure because

the right side of head and neck, right thorax, and right

the

upper extremity and empties into the junction of the

is exceeded.8

inﬂection

point

on

the

compliance

curve

right subclavian vein and right internal jugular vein;

Pericardial pressure varies with respiration; it rises

the thoracic duct drains lymph from the rest of the

with expiration and falls with inspiration.9 Thus, it is

body and empties into the junction of the left sub-

closely related to changes in pleural pressure, 10

clavian vein and the left internal jugular vein.

4

which

are

highly

inﬂuenced

by

diaphragmatic

Drainage of lymph into the venous system is a pas-

movements. In preclinical studies, pleural and peri-

sive process driven by pressure gradients (Figure 1).

cardial pressures have a close relationship in the

Inspiration is also associated with a reduction in

normal resting state throughout the respiratory cycle

LV stroke volume. This may reﬂect pooling of blood

(maximum difference during inspiration/expiration

in pulmonary veins, reducing venous return to the

w3 mm Hg).10 This correlation persists even during

left atrium, an increase in aortic diastolic pressure

positive pressure ventilation. 10 In clinical studies of
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F I G U R E 1 Cardiovascular Physiological Roles of the Diaphragm

Contraction of the diaphragm

Decrease intrathoracic pressure

Decrease pericardial pressure

Increase venous and lymphatic
return

Modulate pericardial pressure

Act as “respiratory pump”

Decrease pleural pressure

Increase afterload,
pulmonary wedge transmural
and aortic transmural
pressures, and LV
end-systolic volume
Modulate LV hemodynamics
The diaphragm exerts cardiovascular physiological roles (eg, modulates pericardial pressure and left ventricular (LV) hemodynamics and acts as a “respiratory pump”).

mechanical ventilation, progressively higher tidal

DIAPHRAGMATIC ABNORMALITIES IN HF

volumes led to greater pericardial pressures with
parallel change in pleural pressures.11 This suggests

The effect of HF on the diaphragm manifests in an

an essential role for the diaphragm in modulating

“afferent” and “efferent” components. HF is typically

pericardial pressures and the possibility to use this

associated with structural and physiological changes

mechanism in addressing conditions marked by

in the diaphragm (ie, efferent effect) that results in

pericardial restraint (Figure 1).

mechanical diaphragmatic dysfunction. The afferent
input from the diaphragm plays an important role in

REGULATING HRV AND MODULATING ARTERIAL

mediating different reﬂexes (eg, metaboreﬂex); such

BAROREFLEX SENSITIVITY. HRV refers to the natu-

reﬂexes trigger complex hemodynamic and respira-

ral ﬂuctuations in the intervals between consecutive
heartbeats and provides an indirect assessment of
autonomic nervous system activity.12 Decreased HRV
indicates

a

heightened

sympathetic

tone,

tory cascades during exercise. Impairment of this
afferent input results in disturbance in exerciserelated hemodynamics (Figure 2).

is

commonly encountered in HF, and is associated with

MUSCLE FIBER ATROPHY AND WEAKNESS. Whereas

increased cardiovascular morbidity and mortality. 13

the global respiratory muscle strength is generally

The diaphragm modulates HRV via its effect on

well preserved in patients with HF at rest, diaphragm

respiration and the resultant hemodynamic changes

weakness is commonly encountered in patients with

during inspiration and expiration. Fluctuations in

HF and predicts exercise intolerance independently

blood pressure subsequently modulate the barore-

from pulmonary dysfunction in these patients.15 In a

ceptor reﬂex system, resulting in HRV. In healthy

study of patients with heart failure with reduced

individuals and patients with ischemic heart disease

ejection fraction (HFrEF) scheduled for LV assist de-

and diabetes, diaphragmatic breathing has been

vice

shown to improve HRV signiﬁcantly. 13

maximum

implantation,
expiratory

maximum
forces

inspiratory
were

and

signiﬁcantly

The diaphragm is also involved in modulating

reduced by 38% and 25% in patients with HFrEF

arterial baroreﬂex sensitivity. In a study of patients

compared with in control subjects. 16 Furthermore,

with hypertension, slow breathing at 6 breaths/min

patients with HFrEF had diaphragm wasting with a

reduced blood pressure and increased baroreﬂex

mean diaphragm thickness that was 23% lower

sensitivity.14

compared with diaphragm thickness in control
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F I G U R E 2 Clinical, Pathological, and Cellular Diaphragmatic Associations With Heart Failure

Symptomatology
• Dyspnea
• Exercise intolerance
• Sleep-disordered breathing
Pathological and cellular
diaphragmatic manifestations
• Muscle fiber atrophy
Clinical diaphragmatic
manifestations

• Altered muscle
metaboreflex
Heart Failure

• pDiaphragm thickness
• pRespiratory muscle
function

• nProteasome-dependent
proteolysis
• nMyofibrillar protein
oxidation

Assessing diaphragmatic
function/dysfunction
Inspiratory muscle
Imaging modalities
force measurements

• Functional and
ultrastructural
mitochondrial
abnormalities

• Chest radiographs • Maximal inspiratory
• Fluoroscopy
pressure (Pimax) is
• Ultrasound
inversely associated
• Magnetic resonance with NYHA
imaging
functional class in
heart failure and is a
predictor of mortality

Heart failure is associated with several physiological and cellular diaphragmatic changes. NYHA ¼ New York Heart Association; Pimax ¼ maximal inspiratory pressure.

subjects.16 At the cellular level, diaphragm biopsies in

products (eg, lactic acid) in skeletal muscles that

patients with HFrEF showed severe ﬁber atrophy

stimulate afferent nerve ﬁbers leading to sympathetic

with increased proteasome-dependent proteolysis,

stimulation with a resultant increase in cardiac

myoﬁbrillar protein oxidation, and severe functional

output and vasoconstriction of nonactive muscles. 18

and ultrastructural mitochondrial abnormalities.

16

In a healthy state, baroreceptor unloading during

INCREASED RATIO OF TYPE I TO TYPE II MUSCLE

muscle metaboreﬂex activation results in an increase

FIBERS. HF is associated with a high proportion of

in mean arterial pressure primarily via an increase in

type I muscle ﬁbers (slow twitch type) in the dia-

cardiac output, whereas in an HF state, baroreceptor

phragm.17 Compared with type II muscle ﬁbers (fast

unloading during muscle metaboreﬂex activation in-

twitch type), type I muscle ﬁbers have higher oxida-

creases mean arterial pressure primarily via vaso-

tive and lower glycolytic capacities. 17 Even though

constriction. In a canine model of HF, baroreceptor

these changes may represent an adaptive mechanism

unloading was simulated by bilateral carotid occlu-

to

sion; 19 this resulted in a pressor response caused by

chronic

hypoxia,

the

implications

are

not

well understood.

peripheral vasoconstriction of all vascular beds

ALTERED MUSCLE METABOREFLEX. Muscle metab-

(including the ischemic active skeletal muscle) with

oreﬂex is a key regulator of the cardiovascular

no preferential vasoconstriction of the nonischemic

exercise response and is triggered by metabolic by-

vasculature,19 suggesting that restoration of blood

Salah et al

JACC VOL. 80, NO. 17, 2022
OCTOBER 25, 2022:1647–1659

Diaphragm Function and Hemodynamics

ﬂow to ischemic active muscles is remarkably atten-

with HF and inspiratory muscle weakness (in whom

uated in HF because of the absence of preferential

maximal inspiratory pressure was <70% of pre-

vasoconstriction of the nonischemic vasculature.

dicted) exhibiting altered activity of the respiratory

Because the diaphragm is metabolically more active

muscle metaboreﬂex, which is shown by signiﬁcant

during exercise, altered diaphragm metaboreﬂex can

reduction of blood ﬂow to resting and exercising

contribute to limited exercise capacity in patients

limbs, a 4-week course of IMT resulted in hypertro-

with HF (Central Illustration).

phy of the diaphragm and improvement in the blood

ASSESSING

DIAPHRAGMATIC

DYSFUNCTION. Several

imaging modalities can be used to assess the diaphragm and its dysfunction. Chest radiographs can be
used to assess diaphragmatic shape, position, and
contour and are typically used for the initial assessment of diaphragmatic dysfunction.

20

Fluoroscopy is

a functional imaging modality that is typically used as
a next step in assessing diaphragmatic elevation seen
on chest radiographs.

20

Ultrasound is an inexpensive

and readily available modality that provides data
related to the diaphragmatic function, excursion,
thickness, and thickening and can be used during
exercise (Figure 3).

21

Magnetic resonance imaging can

be used to study the excursion, synchronicity, and
velocity of diaphragmatic motion.

20

While these mo-

dalities were predominantly studied in the context of
pulmonary diseases, their utility in assessing diaphragmatic dysfunction in patients with HF is
still uncertain.
In addition to imaging modalities, inspiratory
muscle force measurements, such as maximal inspiratory pressure (Pi max), can be used to assess the
degree of diaphragmatic dysfunction in HF. 22 Pi max is
typically reduced in patients with HF, and its degree
of reduction correlates with worsening New York
Heart Association (NYHA) functional class and is a
strong predictor of mortality.22

ﬂow to the resting and exercising limbs with inspiratory muscle loading.24 These results suggest that
IMT in patients with HF can improve the thickness of
the diaphragm, restore diaphragmatic strength, and
improve the activity of the respiratory muscle
metaboreﬂex. Furthermore, this study showed that
IMT in patients with HF can increase the ventilatory
load needed to induce the respiratory muscle
metaboreﬂex-mediated

peripheral

vasoconstric-

tion; 24 this suggests that IMT may be associated with
reduction in the accumulation of the metabolic byproducts of muscles (eg, lactic acid), which are key
regulators of metaboreﬂex activity. IMT also exerts
favorable effect on the inspiratory muscle force
measurements. In a meta-analysis, isolated IMT
showed a statistically signiﬁcant increase in Pi max
by 25.12 cm H 2O.25
Subsequent studies have shown that an exercise
program that consists of combined aerobic training
(AT), resistance training performed on a treadmill or
bicycle at an intensity of 60% to 80% of maximum
heart rate, and IMT is superior to either AT/resistance
training, AT/IMT, or AT alone in improving aerobic
capacity and circulatory power in patients with
HFrEF. 26 Although the effect of AT, resistance
training, and IMT on the cellular and molecular levels
of the diaphragm in humans has not been explored, in
a mice model of HF, aerobic exercise training pre-

TARGETING THE DIAPHRAGM AS TREATMENT

vented contractile dysfunction of diaphragm ﬁber

IN PATIENTS WITH HF

bundles and reduced markers of oxidative stress and
proteolysis.27

Given the vital relationship between the diaphragm

Some of the mechanisms that may underlie the

and cardiac hemodynamics, there is the potential to

beneﬁcial effects of IMT in patients with HF may

use the diaphragm to treat cardiovascular diseases

relate to: 1) attenuation of metaboreﬂex (thus

associated with the disturbance of cardiac hemody-

improving blood ﬂow distribution to skeletal muscles

namics, such as HF.

and delaying muscle fatigue); 2) enhancement of

INSPIRATORY MUSCLE TRAINING IN HF. The struc-

ventilatory efﬁciency; and 3) reduction of ventilatory

tural and biochemical changes of the diaphragm seen

oscillations. 28

in HF can result in inspiratory muscle weakness,

DIAPHRAGMATIC STIMULATION. In a study in 14 pa-

which may be among the main drivers for dyspnea,

tients undergoing cardiac surgery, diaphragm pacing,

fatigue, and exercise intolerance that is observed in

using a transvenous pacing catheter to stimulate the

patients with HF. There is a growing body of evi-

right and left phrenic nerves resulted in reduced

dence suggesting that inspiratory muscle training

pulmonary artery pressure, right atrial pressure, left

(IMT) in patients with HF may counteract these

atrial pressure, and total pulmonary vascular resis-

changes and restore normal/semi-normal diaphrag-

tance

matic and respiratory muscle function. 23 In patients

diac output. 29

with

a

signiﬁcant

augmentation

in

car-
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C E N T R A L IL LU ST R A T I O N Diaphragm as a Therapeutic Target in Cardiovascular Disease

Salah HM, et al. J Am Coll Cardiol. 2022;80(17):1647–1659.

A summary of the physiological cardiovascular roles of the diaphragm, diaphragm abnormalities in heart failure, clinical beneﬁts of diaphragm stimulation
therapy and inspiratory muscle training, and proposed mechanisms for these beneﬁts. LV ¼ left ventricle.
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F I G U R E 3 Imaging Modalities to Assess the Diaphragm Function and Structure

(1, 2) Evaluation of the diaphragm function and structure using bedside ultrasound: (A) pleural side; (B) peritoneal side; (C) lung; (D) rib; (E)
liver and visceral organs. The arrows represent the diaphragm. (3, 4) Evaluation of the diaphragm function and structure using ﬂuoroscopy.
The dashed line represents the diaphragm rest expiratory position (baseline). In (3), the solid line represents the diaphragm position with
maximal inspiration. The arrow represents the change in the diaphragm position from the rest expiratory position to maximal inspiration. In
(4), the solid line represents the diaphragm position at maximal expiration. The arrow represents the change in the diaphragm position from
the rest expiratory position to maximal expiration. (3) and (4) reproduced with permission from Hida et al.49

The hemodynamic effects of pacing-induced dia-

diaphragm following PIDS, suggesting that PIDS can

phragmatic stimulation (PIDS) was ﬁrst observed on

potentially improve LV systolic function. 31 This

patients with permanent pacemakers who are ambu-

favorable effect was achieved regardless of whether

latory and later conﬁrmed on patients who are hos-

subjects were symptomatic or asymptomatic from the

pitalized and undergoing temporary pacing during

diaphragmatic contraction in response to pacing,

electrophysiologic examination. 30

suggesting comparable efﬁcacy. The randomized,

Subsequently, the same group investigated the

open-label, crossover Epiphrenic-II Pilot trial, which

effect of PIDS on cardiac hemodynamics in patients

included patients with HFrEF who were scheduled for

undergoing open-heart surgery, during which a

open cardiothoracic surgery and implantation of a

temporary stimulation lead was attached to the left

combined

dorsal location of the diaphragm. 31 PIDS 20 millisec-

therapy

onds

or

pacemaker/cardiac
implantable

resynchronization

cardioverter-deﬁbrillator/

pacing

cardiac resynchronization therapy for chronic HF,

signiﬁcantly improved electromechanical activation

showed that optimized PIDS modes (ie, optimized

time

delay

after
with

the
no

onset

observed

of

ventricular

desensitization

of

the

to

ventricular

cardiac

resynchronization
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F I G U R E 4 Synchronous Diaphragmatic Stimulation for Heart Failure

(A) The implantable VisONE system, which consists of an implantable pulse generator and leads attached to the inferior surface of the
diaphragm. The VisONE system delivers diaphragmatic pacing that is synchronized to cardiac cycle with adjustable delay using an external
programmer. (B) The anatomic landmarks used during the laparoscopic implantation of the VisONE system. (1) Trocar landmark for the
laparoscope; (2) trocar landmark for inserting sensing/stimulating leads; (3) landmarks for diaphragmatic lead attachment; and (4) subcutaneous pocket. (C) X-ray imaging of fully implanted VisONE system. Used with permission from Jorbendaze et al.50

therapy pulse) resulted in a signiﬁcant improvement

ups at 12-months showed consistent improvement in

in left ventricular ejection fraction (LVEF), improve-

these outcomes with larger effect when diaphrag-

ment in the NYHA functional class, and an increase in

matic synchronization was >80% of pacing.34 Based

the maximal power and oxygen consumption during

on these results, the U.S. Food and Drug Adminis-

exercise testing.32

tration granted ASDS a breakthrough device desig-

Recently, the pilot VisONE Heart Failure Study

nation status in 2020 (Figure 4, Table 1).35,36

investigated the VisONE asymptomatic synchronized

Phrenic nerve stimulation is also used in the

diaphragmatic stimulation (ASDS) system, which

management of central sleep apnea (CSA), which is

consists of an implantable pulse generator and leads
attached to the inferior surface of the diaphragm, and

prevalent in HF. 35 Phrenic nerve stimulation during
 System (Respicardia Inc), an
sleep using the remed e

showed that a transabdominal laparoscopic implan-

implantable device that results in diaphragmatic

tation of the VisONE ASDS system in patients with

contraction with restoration of normal breathing

HFrEF (LVEF #35%), NYHA functional class II-III

pattern during sleep. The cumulative evidence from

symptoms, and no ventricular dyssynchrony results

the pilot and pivotal trials with moderate to severe

in an acute improvement in LVEF, cardiac output,

CSA demonstrated that phrenic nerve stimulation

and 6-minute walk distance, and a decrease in heart

signiﬁcantly reduces apnea-hypopnea index, im-

rate at 1 month following the implantation. 33 Follow-

proves quality of life, and oxygenation at 6 months
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T A B L E 1 Studies Investigating the Role of Long-Term Diaphragmatic Stimulation on Cardiovascular Outcomes in Humans

Study, Ref. #

Year

Population

Intervention

Number of
Participants

Major Results

Ishii et al29

1990 Patients undergoing cardiac surgery

Bilateral diaphragm pacing

14

Bilateral diaphragm pacing reduced pulmonary artery pressure,
right atrial pressure, left atrial pressure, and total pulmonary
vascular resistance with a signiﬁcant augmentation in cardiac
output

Roos et al31

2008 Patients undergoing cardiac surgery

Pacing-induced
diaphragmatic stimulation

35

Stimulation improved electromechanical activation time with no
observed diaphragm desensitization

Beeler et al,32
Epiphrenic II
Pilot Trial

2014 Patients with chronic heart failure and
cardiac resynchronization therapy

Attaching an additional
electrode to the left
diaphragm for diaphragm
stimulation

24

Diaphragm stimulation improved left ventricular ejection
fraction, dyspnea, and working capacity

Zuber et al,33
2019 Patients with LVEF #35%, moderatePilot VisONE
severe heart failure symptoms, and
Heart Failure
no evidence of ventricular
Study
dyssynchrony

Laparoscopic implantation of
the VisONE ASDS system

15

VisONE ASDS system resulted in an improvement in LVEF,
cardiac output, and 6-minute walk distance, and a decrease
in heart rate at 1 month with consistent improvement in
these outcomes at 3, 6, and 12 months with larger effect
when diaphragmatic synchronization was >80% of pacing

ASDS ¼ asymptomatic synchronized diaphragmatic stimulation; LVEF ¼ left ventricular ejection fraction.

with sustained results through 5 years following implantation

(Figure

5).37,38

These

beneﬁts

the conversion of unstressed to stressed blood vol-

were

ume by means of central blood volume recruitment

consistent in patients with CSA and HF, and in par-

(eg, from lower extremities and abdominal compart-

allel, phrenic nerve stimulation resulted in a signiﬁ-

ment) with resultant increase in preload. 40 The cen-

cant improvement in HF quality of life as measured

tral blood volume recruitment process occurs in

by the Minnesota Living With Heart Failure Ques-

response to venous constriction via baroreﬂex- and

tionnaire.39 Whereas hospitalizations for HF were

chemoreﬂex-mediated sympathoactivation.40 In the

numerically lower with treatment (4.7% in the treat-

lower extremities, this process is aided by skeletal

ment group vs 17% in the control group) at 6 months,

muscle contraction. 41 In the abdominal compartment,

this difference did not reach a statistical signiﬁcance

almost 400 mL of blood volume is recruited centrally

(P ¼ 0.065). 39 These ﬁndings signal a possible direct

from the splanchnic circulation in response to phys-

or indirect effect for phrenic nerve stimulation on HF

ical activity. 42 This shift is, in large part, aided by the

beyond the effect on CSA.

contraction of the diaphragm. 43 Preload reserve refers

POTENTIALS MECHANISMS BY WHICH
DIAPHRAGMATIC STIMULATION IMPROVES
CARDIAC OUTCOMES IN PATIENTS WITH HF

to the ability of the cardiovascular system to enhance
cardiac output in response to increased preload
without a signiﬁcant increase in ventricular ﬁlling
pressure and is typically impaired in patients with
HF. 40 ASDS-induced diaphragmatic movement can

The exact mechanisms by which diaphragmatic

potentially increase preload as a result of the central

stimulation drive the cardiovascular beneﬁts and

blood volume recruitment from the splanchnic cir-

improved hemodynamics in HF are not well under-

culation.44 In patients with HF, the Frank-Starling

stood, partially because of the lack of studies

mechanism plays a limited role in augmenting car-

exploring its pathophysiology and partially because,

diac output in response because the failing heart

until recently, there was a lack of therapeutic options.

typically operates on the relatively ﬂat portion of the

We propose the following mechanisms that may

Frank-Starling curve. ASDS likely overcomes this

individually and/or cumulatively drive such beneﬁts

limitation by mechanically aiding cardiac function,

in patients with HF:

decreasing the heart’s work burden, and improving

IMPROVING PRELOAD RESERVE. ASDS results in an

cardiac energy expenditure with subsequent favor-

asymptomatic but palpable diaphragmatic move-

able cardiac remodeling. Favorable cardiac remodel-

ment, which is characterized by a focal caudal dia-

ing (reduction in LV end-systolic dimension) in

phragmatic movement followed by backward cranial

response to mechanical aid with ASDS may be among

movement superimposed on the regular respiration

the mechanisms underlying the improvement in

movements.32 These movements can favorably affect

LVEF and LV end-systolic volume seen with ASDS.

loading and unloading of the heart.

Diaphragmatic contraction generated by ASDS may

In healthy individuals, augmentation of cardiac

also function as an “auxiliary heart” in series with the

output during physical activity depends largely on

native heart that aids in pumping blood from the
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F I G U R E 5 Phrenic Nerve Stimulation in Central Sleep Apnea

Percentage Change
in AHI (%)

A

Treatment
100
50
0
–50
–100
1

4

7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52 55 58 61
Patients (n = 61)

B

Control
150

Percentage Change
in AHI (%)
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100
50
0
–50
–100
1 4 7 10 13 16 19 22 25 28 31 34 37 40 43 46 49 52 55 58 61 64 67 70 73
Patients (n = 73)
Increase

Decrease

Phrenic nerve stimulation in patients with central sleep apnea results in restoration of normal breathing pattern. Modiﬁed with permission
from Costanzo et al.
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AHI ¼ apnea/hypopnea index.
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trunk into the extremities. In a study of healthy in-

function throughout the cardiac cycle. It is typically

dividuals performing plantar ﬂexion exercise at

exaggerated in different phenotypes of HF because of

4 METS, plethysmography was used to measure

an increase in cardiac volumes.8 In patients with

changes in body and trunk volumes during 3 types of

normal LVEF undergoing pericardiotomy for elective

breathing (spontaneous breathing, rib cage breathing,

coronary artery bypass surgery, there was an increase

and abdominal breathing).45 During spontaneous and

in LV end-diastolic volume and LV mass indices with

rib cage breathing, blood was displaced from the ex-

no change in end-systolic circumferential wall stress

tremities into the trunk (an average of 160 mL during

or end-systolic volume, suggesting that targeting

spontaneous breathing and 478 mL during rib cage

pericardial restraint could improve diastolic ﬁlling

breathing), whereas an average of 225 mL of blood

and result in myocardial growth with no adverse

was displaced from the trunk into the extremities

cardiac remodeling.47

during abdominal breathing (predominantly dia-

ASDS-induced diaphragmatic movement can result

phragm breathing).45 Collectively, these mechanisms

in a negative intrathoracic pressure with subsequent

likely result in overcoming preload reserve failure,

“micro” reduction in pericardial pressure, which

improving cardiac output, and enhancing perfusion.

would improve cardiac ﬁlling conditions and systolic

IMPROVING

ATRIOVENTRICULAR

SYNCHRONY. ASDS

potentially exerts beneﬁcial effects by improving
atrial and ventricular synchrony. With dual-chamber
pacing alone, it has been demonstrated that a properly timed, effective atrial contraction is important
for optimal LV systolic function because such
contraction increases LV end-diastolic pressure while
maintaining a low mean left atrial pressure.

46

This

optimal mechanical atrial and ventricular synchrony
can be re-established in patients with severe LV
dysfunction with a resultant increase in cardiac
output by atrioventricular sequential pacing.

46

With

diaphragmatic pacing, swings in intrathoracic and
pericardial pressures affect cardiac loading conditions and atrioventricular synchrony. Initial caudal
diaphragmatic movement induced by ASDS generates
a negative intrathoracic pressure gradient that is
transmitted to the pericardium, pulling outward on
the ventricles during late diastole and allowing for an
increase in the atrial contribution to LV ﬁlling during

performance. A decrease in the intrathoracic pressure
results in a similar decrease in the pericardial pressure even in conditions of increased pericardial restraints, such as tamponade. 10 The decrease in
intrathoracic pressure transmitted to the pericardial
space generates an increased atrial transmural pressure gradient that works to reduce atrial pressure and
augment atrial ﬁlling with more volume at lower
pressures. Because atrial pressure and volume reﬂects loading conditions of the ventricles, an increase
in atrial blood volume at a lower pressure allows the
corresponding ventricle to subsequently ﬁll at lower
pressure with higher volumes as well, reﬂecting
increased

ventricular

compliance.

This

salutary

change in ventricular compliance works in conjunction with preload to recruit the other beneﬁcial
changes of LV afterload reduction, preload reserve,
and increased cardiac output.
IMPROVING METABOREFLEX ACTIVITY AND RESTORATION
OF DIAPHRAGM STRENGTH BY MUSCLE TRAINING. As we

This initial ASDS-induced caudal dia-

already discussed, HF is associated with altered

phragmatic movement and changes in loading con-

metaboreﬂex activity, weakness and atrophy of the

diastole.

32

ditions with improved atrial contribution to LV ﬁlling

diaphragm muscle ﬁbers, and increased type-I muscle

in late diastole may also be able to re-establish the

ﬁbers to type-II muscle ﬁbers ratio. Prospective

mechanical synchrony lost in HF states. Following

studies showed that inspiratory muscle training in

caudal displacement, the diaphragmatic movement

patients with HF can lead to signiﬁcant improvement

induced by ASDS is cranial and is typically much

in metaboreﬂex activity.48 It is possible that chronic

faster than the regular diaphragmatic movement.

stimulation of the diaphragm with ASDS would result

Cranial displacement of the diaphragm increases

in diaphragm training with subsequent improvement

intrathoracic and pericardial pressure, which acts as

in metaboreﬂex activity, tissue remodeling, and

an extracardiac compressive force, augmenting ven-

optimization of diaphragmatic energy metabolism.

tricular contraction during systole.

This may translate clinically to an improvement in

41

REDUCING PERICARDIAL RESTRAINT. The pericar-

dium plays an important and under-recognized role
in the pathophysiology of HF via its compressive

exercise capacity that is independent from pulmonary function.

FUTURE DIRECTIONS

contact force on the surface of the myocardium (ie,
restraint). 8

is

This review highlights the underappreciated role of

involved in modulating the hemodynamics of cardiac

the diaphragm in the cardiovascular system and its

pericardial

Pericardial

restraint

1657

1658
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potential as a target therapy in patients with HF.

pressures, regulates HRV, and improves baroreﬂex

However, there is a need for studies investigating

sensitivity. HF is commonly associated with dia-

the diaphragmatic changes associated with different

phragmatic dysfunction; targeting the diaphragm (via

HF phenotypes (eg, HFrEF vs HF with preserved

device stimulation therapy or inspiratory muscle

ejection fraction). Most of the current evidence

training) may provide a novel treatment pathway for

supporting diaphragm-based therapies as a potential

HF.

therapeutic pathway in patients with HF is driven
by studies that included an HFrEF population,
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